Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Epileptic disorders : international epilepsy journal with videotape · 2021
    ZGZachary GrinspanSNSrishti Nangia
    PMID: 33622664DOISenior author14 citations

Publications

29 publications

Funding

2 grants
Completed grants (2)
  • Sub-PI
    FAST Emergency Care Consortium
    Foundation for Angelman Syndrome Therapeutics · 2021–2022 · via University of Colorado Denver
    FT2021-003
  • PI
    Consultant Agreement
    Medpace, Inc. · 2020–2021Contract
    CA 203207-01

Clinical research

3 studies

Active

1 study
  • PI
    A Long-term Extension Trial Investigating the Safety and Efficacy of GTX-102 in Patients With Angelman Syndrome
    PHASE3 · Ultragenyx Pharmaceutical Inc. · OPEN TO ACCRUAL (as of 2024)
    Angelman Syndrome
    NCT06415344
Completed & closed trials (2)
  • PI
    Clinical Needs of Individuals with a Chromosome 15 Condition
    The Angelman Syndrome Foundation · IRB STUDY CLOSURE (as of 2026)
  • PI
    A Phase 1/2 Open-label, Multiple-dose, Dose-escalating Clinical Trial of the Safety and Tolerability of GTX-102 in Pediatric Patients With Angelman Syndrome (AS)
    PHASE1; PHASE2 · Ultragenyx Pharmaceutical Inc. · IRB STUDY CLOSURE (as of 2025)
    Angelman Syndrome
    NCT04259281